India Exchange Filings

NATCO Pharma Q2FY27 Results and Dividend Highlights

Natco Pharma Ltd approves Q2FY27 results and declares a second interim dividend of ₹1.25 per share

  • Q2 consolidated revenue was ₹1,019.4 crore, up 28.3% sequentially and down 30.3% year on year.
  • Net profit was ₹202.6 crore, down 1.9% sequentially and 60.9% year on year; EBITDA margin was 30.4%.
  • Record date: November 19, 2026; dividend payment starts November 27, 2026. Consolidated results received an unmodified limited-review report.

Original Filing

This is an automated summary of a public document. Always check the original before relying on it.